Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

EGX:SIPC Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.52	1.94	0.61	0.42	0.15	4.87
Cash & Short-Term Investments	4.52	1.94	0.61	0.42	0.15	4.87
Cash Growth	160.32%	217.85%	44.30%	183.26%	-96.93%	-39.65%
Accounts Receivable	3.87	10.13	4.9	7.95	7.54	11.42
Other Receivables	0.05	0.05	0.05	0.07	0.75	1.62
Receivables	13.56	22.91	13.71	8.99	13.9	13.09
Inventory	40.14	39.81	42.24	50.45	32.3	28.85
Prepaid Expenses	-	-	-	-	0.07	0
Other Current Assets	7.79	1.39	5.91	2.89	0.12	1.35
Total Current Assets	66	66.06	62.47	62.76	46.54	48.15
Property, Plant & Equipment	102.43	102.95	106.28	107.37	109.16	107.46
Other Intangible Assets	-	0.02	0.01	0.22	-	-
Long-Term Deferred Charges	-	-	-	-	0.35	0.38
Other Long-Term Assets	-	-	0	-	-	-
Total Assets	168.43	169.02	168.76	170.35	156.05	155.99

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	24.22	21.09	22.26	14.16	1.67	1.25
Accrued Expenses	2.89	2.37	3.43	2.6	2.38	1.83
Short-Term Debt	16.62	16.26	24.26	20.43	0.3	4.04
Current Portion of Long-Term Debt	7.09	8.19	4.43	4.08	-	-
Current Portion of Leases	-	-	-	0	-	-
Current Income Taxes Payable	3.54	3.54	3.19	3.19	2.89	3.56
Other Current Liabilities	11.51	9.44	10.31	6.05	12.2	9.26
Total Current Liabilities	65.87	60.9	67.89	50.52	19.44	19.94
Long-Term Debt	-	-	3.69	2.68	20.35	20.25
Long-Term Deferred Tax Liabilities	2.11	2.5	1.64	2.21	1.19	0.24
Total Liabilities	67.98	63.41	73.23	55.4	40.97	40.43

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	100	100	100	100	100	100
Retained Earnings	0.45	5.62	-4.47	14.95	15.07	15.56
Shareholders' Equity	100.45	105.62	95.53	114.95	115.07	115.56
Total Liabilities & Equity	168.43	169.02	168.76	170.35	156.05	155.99

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	23.71	24.46	32.39	27.19	20.64	24.28
Net Cash (Debt)	-19.19	-22.51	-31.78	-26.76	-20.49	-19.42
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.08	-0.09	-0.13	-0.11	-0.08	-0.08
Filing Date Shares Outstanding	250	250	250	250	250	250
Total Common Shares Outstanding	250	250	250	250	250	250
Working Capital	0.13	5.15	-5.42	12.24	27.1	28.21
Book Value Per Share	0.40	0.42	0.38	0.46	0.46	0.46
Tangible Book Value	100.45	105.6	95.52	114.73	115.07	115.56
Tangible Book Value Per Share	0.40	0.42	0.38	0.46	0.46	0.46
Land	7.6	7.6	7.6	7.6	7.6	7.6
Buildings	111.38	111.38	111.38	111.38	110.51	89.72
Machinery	22.31	22.25	22.24	21.17	19.76	18.62
Construction In Progress	0.16	0.16	-	-	-	16.49

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error